Topic

Commercial Pharmaceutical

Page:
1

Case study: Partnering with the National Cancer Institute to advance COVID-19 research

Background While the COVID-19 pandemic is behind us, the virus remains a concern that needs to be studied. In the first half of 2024 alone, over 23,000 people in the United States died of the disease. The virus also continues to evolve, with the FDA ...

Contact us